1lz6r G Jr, Paszt A, Simonka Z, et al. A successful strategy for surgical treatment of Boerhaave's syndrome [ J ]. Surg Endosc, 2011,25 ( 11 ) : 3613-3619.
2Mahmodlou R, Abdirad I, Ghasemi-Rad M. Aggressive surgical treat- ment in late-diagnosed esophageal perforation : a report of 11 cases[ J ]. ISRN Surg,2011,2011:868356.
3Wang Y, Zhang R, Zhou Y, et al. Our experience on management of Boerhaave syndrome with late presentation[ J]. Dis Esophagus,2009, 22( 1 ) :62-67.
4Sung SW,Park JJ,Kim YT,et al. Surgery in thoracic esophageal perfo- ration: primary repair is feasible [ J ]. Dis Esophagus, 2002 ,15 (3): 204-209.
1Kotsis L, Kostic S, Zubovits K. Multimodality treatment of esophageal disruptions[J]. Chest, 1997,112(5) : 1304-1309.
2Linden P A, Bueno R, Mentzer S J, et al. Modified T tube repair of delayed esophageal perforation results in a low mortality rate similar to that seen with acute perforations[J]. Ann Thorac surg,2007,83(3):1129-1133.
3Kiernan P D, Sheridan M J, Elster E, et al. Thoracic esophageal perforations[J]. South Med J,2003,96(2):158-163.
4Reeder L B, DeFilippi V J, Ferguson M K. Current results of therapy for esophageal perforation[J]. Am J Surg,1995,169(6) :615-617.
5Lundell L, Liedman B, Hyltander A. Emergency oesophagectomy and proximal deviating oesophagostomy for fulminent mediastinal sepsis[J]. Eur J Surg,2001,167(9):675-678.
7O'Sullivan ST, Lederer JA, Horgan AF, et al. Major injury leads to predominance of the T-helper lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg, 1995, 222:482-490.
8Wei RQ, Schwartz CF, Lin H, et al. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts. J Surg Res, 1999, 81:123-128.
9Antoniou KM, Ferdoutsis E, Bouros D. Interferons and their application in the diseases of the lung. Chest, 2003, 123:209-216.
10Yang X. Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology. Curr Pharm Des, 2003, 9:67-73.
